Lymphocyte subset numbers depend on the bacterial origin of sepsis

Clinical Microbiology and Infection

Volumn 9, Issue 3, 2003, Pages 202-211

  Holub, M ^a,b   Kluckova Z ^a   Helcl, M ^c   Prihodov J ^c   Rokyta, R ^d   Beran, O ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b WADSWORTH CENTER   (United States)

^c UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Etiology; Lymphocyte subsets; Sepsis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NEISSERIA MENINGITIDIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; NEGIBACTERIA; NEISSERIA; NEISSERIA MENINGITIDIS; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0344837417     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00518.x     Document Type: Article

References (42)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinski MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.
2. Munford RS. Sepsis and septic shock. In: Fauci AS, Braunwald E, Isselbacher KJ et al., eds. Harrison's principles of internal medicine, 14th edn. New York: McGraw-Hill, 1998: 776-80.
3. Volk HD, Reinke P, Docke WD. Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 2000; 74: 162-77.
4. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression. Immunol Res 2001; 24: 273-87.
5. Volk HD, Reinke P, Krausch D et al. Monocyte deactivation - rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996; 22(suppl 4): S74-81.
6. Wenish C, Parschalk P, Hasenhundl M, Griesmacher A, Graninger W. Polymorphonuclear leykocyte dysregulation in patients with gram-negative bacteraemia assessed by flow cytometry. Eur J Clin Invest 1995; 25: 418-24.
7. + expression in sepsis. Clin Microbial Infect 2000; 6: 657-60.
8. Ferguson NR, Galley HF, Webster NR. T helper cell subset ratios in patients with severe sepsis. Intensive Care Med 1999; 25: 106-9.
9. + T-lymphocytes in human. J Immunol 2001; 166: 6952-63.
10. Cheadle WG, Pemberton MR, Robinson D, Livingston DH, Rodriguez JL, Pokl HC. Lymphocyte subsets responses to trauma and sepsis. J Trauma 1993; 35: 844-9.
11. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80: 205-9.
12. Williams RC, Kostler FT, Kilpatrick KA. Alteration in lymphocyte cell surface markers during various human infections. Am J Med 1983; 75: 807-16.
13. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definition of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 374-83.
15. Moreno R, Vincent JL, Matos R et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the ESICM. Intensive Care Med 1999; 25: 686-96.
16. Yentis SM, Soni I, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995; 21: 602-5.
17. Vesel R, Barths J, Vanlangendonck F, Hannet I, Struss K. Initial results of central European immunophenotyping quality control program. Cytometry 1996; 26: 108-12.
18. Goldsby RA, Kindt TJ, Osborne BA, eds. Kuby immunology, 4th edn. New York: W. H. Freeman and Co.
19. Toft P, Dagnaes-Hansen F, Tønnesen E, Basse PM. The effect of surgical stress and endotoxin-induced sepsis on the NK-cell activity, distribution and pulmonary clearance of YAC-1 and melanoma cells. APMIS 1999; 107: 359-64.
20. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993; 5: 503-10.
21. Johnson RM, Brown EJ. Cell-mediated immunity in host defense against infectious diseases. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia: Churchill Livingstone, 2000: 112-46.
22. Docke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 1997; 3: 678-81.
23. Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 2000; 173: 17-26.
24. Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from Gram-negative sepsis? Crit Care Med 1999; 27: 1608-16.
25. Hotchkiss RS, Swanson PE, Freeman BD et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-51.
26. Medzhitov R, Janeway ChA. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4-9.
27. Ditschowski M, Kreuzfelder E, Majetschak M, Obertacke U, Schade VF, Grosse-Wilde H. Reduced B cell HLA-DR expression and natural killer cell count in patients prone to sepsis after injury. Eur J Surg 1999; 165: 1129-33.
28. Lemaire LCJM, Van Deventer SJH, Van Lanschot JJB, Meenan J, Gouma DJ. Phenotypical characterization of cells in the thoracic duct of patients with and without systemic inflammatory response syndrome and multiple organ failure. Scand J Immunol 1998; 47: 69-75.
29. Monig H, Arendt T, Meyer M, Kloehn S, Bewig B. Activation of the hypothalamo-pituitary-adrenal axis in response to septic or non-septic diseases - implication for the euthyroid sick syndrome. Intensive Care Med 1999; 25: 1402-6.
30. Dhabhar FS, Miller AH, McEwen BS, Spencer RL. Stress-induced changes in blood leukocyte distribution. J Immunol 1996; 157: 1638-44.
31. Payen D, Faivre V, Lukaszewicz AC, Losser MR. Assessment of immunological status in the critically ill. Minerva Anestesiol 2000; 66: 351-7.
32. Dongsoo K, Reilly A, Lawrence DA. Relationship between IFNγ, IL-6, corticosterone, and Listeria monocytogenes pathogenesis in BALB/c mice. Cell Immunol 2001; 207: 13-18.
33. Dhabhar FS, Miller AH, McEwen BS, Spencer RL. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J Immunol 1995; 154: 5511-27.
34. Kizil G, Todd I, Atta M, Borriello SP, Ait-Tahar K, Ala'Aldeen DA. Identification and characterization of TspA, a major CD4 (+) T-cell- and B-cell-stimulating Neisseria-specific antigen. Infect Immun 1999; 67: 3533-41.
35. Goodier MR, Londei M. Low concentration of lipopolysaccharide synergize with peptides to augment T-cell proliferation and can prevent the induction of non-responsiveness by CTLA4-Ig. Immunology 2001; 102: 15-23.
36. Miyamoto YJ, Wann ER, Fowler T, Duffield E, Hook M, McIntyre BW. Fibronectin binding protein A of Staphylococcus aureus can mediate human T lymphocyte adhesion and coactivation. J Immunol 2001; 166: 129-38.
37. Arva E, Andersson B. Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand J Immunol 1999; 49: 237-43.
38. Janssen O, Sanzenbacher R, Kabelitz D. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res 2000; 301: 85-99.
39. Abdelnour A, Tarkowski A. Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines. Cell Immunol 1993; 147: 279-93.
40. Helmby H, Jonsson G, Troye-Blomberg M. Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun 2000; 68: 6087-9.
41. Lin RY, Astiz ME, Saxon JC, Rackow EC. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 1993; 104: 847-53.
42. Benjamini E, Sunshine G, Leskowitz S, eds. Immunology, a short course, 3rd edn. New York: Wiley-Liss, 1996: 199-202.